Cite
MLA Citation
Carmelo Tibaldi. “Research Highlights: Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer.” Pharmacogenomics, vol. 15, 2014, pp. 133–135. http://access.bl.uk/ark:/81055/vdc_100140417474.0x00000f